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Introduction {#sec1}
============

Reactive oxygen species (ROS) such as H~2~O~2~ cause oxidative damage that is linked with many diseases and aging. Hence, cells use H~2~O~2~ as a signaling molecule to initiate transcriptional responses to limit this damage. For example, in fungi, following activation by H~2~O~2~-induced oxidation of specific cysteines, AP-1-like transcription factors promote expression of ROS defense and repair enzymes (reviewed in [@bib35]). In pathogenic fungi, this is a vital response to ROS generated by host immune cells ([@bib13; @bib18]). As well as the activation of ROS defenses, H~2~O~2~ signals also regulate fundamental processes, including cell division, differentiation, migration, and death. In many cases, the H~2~O~2~-sensing/-signaling mechanisms are poorly defined. However, these H~2~O~2~ responses also involve the oxidation of specific, redox-sensitive cysteine residues present in a variety of target proteins, including protein tyrosine phosphatases, kinases, and ubiquitin/ubiquitin-like pathway enzymes (for a review, see [@bib35], and also [@bib5; @bib10; @bib21]).

2-Cys peroxiredoxins (Prxs) are highly abundant peroxidase enzymes that play important roles in responses to H~2~O~2~. Indeed, Prxs have crucial roles in maintaining genome stability, protecting against cancer and promoting longevity (for reviews, see [@bib27; @bib29]). Prxs use reversibly oxidized cysteines to catalytically break down peroxides ([Figure S1](#app2){ref-type="sec"}) but have additional chaperone and signaling activities ([@bib29]). It is currently unclear how each of these activities contributes to Prx's in vivo roles. There is also considerable interest in understanding how Prxs influence H~2~O~2~ signaling. Significantly, the peroxide-reacting (peroxidatic) cysteine in Prx is far more abundant and sensitive to H~2~O~2~ than redox-sensitive cysteines in H~2~O~2~-regulated-signaling proteins. Hence, it is not clear how H~2~O~2~ targets signaling proteins in cells rich in Prx ([@bib38]). Several mechanisms have been proposed to answer this question, as described below.

The thioredoxin peroxidase activity of eukaryotic 2-Cys Prx is susceptible to inactivation by hyperoxidation of the peroxidatic cysteine residue at relatively low levels of H~2~O~2~ ([@bib41]) ([Figure S1](#app2){ref-type="sec"}). It has been proposed that this inactivation may allow H~2~O~2~ to evade Prx-mediated breakdown and oxidize target-signaling proteins ([@bib41]). Indeed, inhibition of the thioredoxin peroxidase activity of Prx by phosphorylation does promote certain ROS-signaling events ([@bib40]). However, there is little evidence that the low levels of H~2~O~2~ sufficient to activate many signaling pathways cause significant Prx hyperoxidation ([@bib40]). Moreover, in the model yeast *Schizosaccharomyces pombe*, the thioredoxin peroxidase activity of the 2-Cys Prx, Tpx1, is required for the H~2~O~2~-induced activation of the AP-1-like transcription factor Pap1. Accordingly, hyperoxidation of Tpx1 actually prevents Pap1 activation ([@bib3; @bib37]).

An alternative mechanism has been proposed to explain the increasing number of examples where Prxs are required for H~2~O~2~-induced signal transduction ([@bib3; @bib4; @bib9; @bib12; @bib15; @bib30; @bib34; @bib37]). Pioneering studies in the yeast *Saccharomyces cerevisiae* revealed that the H~2~O~2~-induced oxidation of the AP-1-like transcription factor Yap1 (Pap1 homolog) is initiated by the formation of a disulfide complex between the Prx-related peroxidase, Gpx3(Orp1), and Yap1 ([@bib9]). Thus, it has been proposed that Prxs positively transduce H~2~O~2~ signals by participating directly in the H~2~O~2~-induced oxidation of signaling proteins ([@bib15; @bib31; @bib38]). However, no Tpx1-Pap1 disulfide complex has been reported ([@bib3; @bib37]).

Our recent studies lead us to propose an additional mechanism by which Prxs can promote H~2~O~2~ signaling: by stimulating the oxidation of thioredoxin. Thioredoxin provides the electrons that reduce Prxs as part of their catalytic cycle ([Figure S1](#app2){ref-type="sec"}). However, as broad specificity oxidoreductases, thioredoxins also reduce many other oxidized proteins ([@bib22]). Our studies revealed that, in *S. pombe* exposed to H~2~O~2~, Tpx1 disulfides are the major substrate for the single cytoplasmic thioredoxin, Trx1 ([Figure S1](#app2){ref-type="sec"}). Accordingly, because thioredoxin reductase (Trr1) levels are limiting, Trx1 becomes completely oxidized, and other Trx1-dependent enzymes are inhibited ([@bib7]). Eukaryotic cells contain many thioredoxin-like enzymes that function as cofactors for particular enzymes and/or to regulate specific signaling proteins ([@bib22]). Hence, we proposed that the coupling of the peroxidase activity of 2-Cys Prx to thioredoxin provides a mechanism for the H~2~O~2~-dependent regulation of multiple thioredoxin substrates ([@bib7]).

Here, we test the hypothesis that Prxs promote H~2~O~2~ signaling by inhibiting thioredoxin family proteins. In support of this hypothesis, we show that the thioredoxin peroxidase activity of Tpx1 is essential for the H~2~O~2~-induced oxidation of the conserved, proteasome-associated thioredoxin-like protein Txl1 (homolog of human TRP32/Txnl1). Significantly, we identify Pap1 as an in vivo Txl1 substrate and show that, by reducing Pap1, Txl1 inhibits the accumulation of oxidized (active) Pap1. Thus, we describe an in vivo role for Txl1 as an inhibitor of H~2~O~2~ signaling. Moreover, we reveal that Pap1 is regulated by a mechanism in which a Prx propagates the H~2~O~2~ signal by inhibiting conserved thioredoxin family protein(s). This has significant implications for the role of Prx and thioredoxin reductase enzymes in H~2~O~2~ signal transduction. Remarkably, our data suggest that the key function for the thioredoxin peroxidase activity of Tpx1 in H~2~O~2~ resistance is to inhibit Txl1. This suggests that the regulation of thioredoxin family proteins may make a major contribution to the in vivo roles of Prxs.

Results {#sec2}
=======

Tpx1 Regulates Pap1 by a Trx1-Independent Pathway {#sec2.1}
-------------------------------------------------

The thioredoxin peroxidase activity of Tpx1 is important for the H~2~O~2~-induced oxidation and nuclear accumulation of Pap1, although the mechanism(s) involved is not clear ([@bib3; @bib37]). The prevalence of Tpx1 disulfide substrates in H~2~O~2~-treated cells causes severe depletion of reduced Trx1 ([@bib7]). This suggests that Tpx1 might promote Pap1 activation by preventing the reduction of oxidized, active Pap1 by Trx1 ([Figure 1](#fig1){ref-type="fig"}A). We reasoned that if Tpx1's only role in Pap1 oxidation is to prevent Trx1 from reducing Pap1, then Tpx1 would not be required for Pap1 oxidation in Δ*trx1* cells ([Figure 1](#fig1){ref-type="fig"}A). However, whereas Pap1 oxidation and nuclear accumulation were detected in unstressed Δ*trx1* cells and increased following H~2~O~2~ treatment, Pap1 was reduced and cytoplasmic in both unstressed and H~2~O~2~-treated Δ*tpx1*Δ*trx1* cells ([Figures 1](#fig1){ref-type="fig"}B, 1D, and 1E). Collectively, these data indicate a Trx1-independent role for Tpx1 in Pap1 activation.

Pap1 is constitutively nuclear and oxidized in cells lacking the single thioredoxin reductase (Trr1) ([Figures 1](#fig1){ref-type="fig"}C--1E) ([@bib36]) and substantially more oxidized compared with Δ*trx1* cells ([Figures 1](#fig1){ref-type="fig"}B--1D). Furthermore, whereas the proportion of oxidized Pap1 in Δ*trx1* cells increased following H~2~O~2~ treatment, Pap1 was maximally oxidized in Δ*trr1* cells even prior to H~2~O~2~ treatment ([Figures 1](#fig1){ref-type="fig"}B--1D). These data raised the possibility that, in addition to Trx1, Trr1 reduces another Pap1-reducing protein(s). Strikingly, analysis of Δ*tpx1* and Δ*tpx1*Δ*trr1* cells revealed that Tpx1 was no longer required for oxidation and nuclear accumulation of Pap1 in the absence of thioredoxin reductase ([Figures 1](#fig1){ref-type="fig"}C--1E). These data suggest that the role of Tpx1 in Pap1 oxidation might be to promote the H~2~O~2~-induced oxidation of this second, unidentified, substrate of Trr1.

The Redox State of the Thioredoxin-like Txl1 Is Regulated by Tpx1 and Trr1 {#sec2.2}
--------------------------------------------------------------------------

In addition to Trx1, the *S. pombe* genome encodes two other thioredoxin-like proteins: Trx2 ([@bib20]), and Txl1(Trx3) ([@bib16]). Because Trx2 localizes to mitochondria ([@bib24]), it was unlikely to reduce cytosolic or nuclear Pap1. Txl1 is larger than typical thioredoxins, consisting of an N-terminal thioredoxin domain and a PITH (C-terminal proteasome-interacting domain of thioredoxin-like) domain, which is important for interaction with the 26S proteasome ([@bib1; @bib39]). Interestingly, loss of Txl1 delays the recovery of cells exposed to the peroxide *t*-BOOH, suggesting a link between Txl1 and oxidative stress responses ([@bib16]). Hence, to investigate the relationship between Txl1 and oxidative stress responses, we first constructed a strain expressing Flag epitope-tagged Txl1 (Flag-Txl1) from its endogenous locus and confirmed that the Flag-Txl1 protein complemented the *t*-BOOH-induced growth delay of Δ*txl1* cells (data not shown). In contrast to Trx1, which is excluded from the nucleus ([@bib7]; [Figure 2](#fig2){ref-type="fig"}A), as expected, immunostaining analysis revealed that Flag-Txl1 is distributed throughout the cytoplasm and the nucleus, with a punctate-staining pattern consistent with interaction with the proteasome ([Figure 2](#fig2){ref-type="fig"}A) ([@bib2; @bib16; @bib24]). Unfortunately, Flag antibodies detected nonspecific (ns) bands present in cells expressing untagged wild-type Txl1 (*txl1*^+^), including a band with a similar mobility to oxidized Flag-Txl1 ([Figures 2](#fig2){ref-type="fig"}B and 2D--2F). However, consistent with Txl1 being a thioredoxin reductase (Trr1) substrate, Flag-Txl1 was completely oxidized in Δ*trr1* cells ([Figure 2](#fig2){ref-type="fig"}B). Our previous work revealed that in wild-type cells treated with 0.2 mM H~2~O~2~, Trr1 levels are insufficient to counter the rate at which Trx1 becomes oxidized during the reduction of Tpx1-Tpx1 disulfide substrates. Hence, Trx1 becomes predominantly oxidized ([Figure S1](#app2){ref-type="sec"}) ([@bib7]). Similarly, Flag-Txl1 was rapidly and transiently completely oxidized in response to 0.2 mM H~2~O~2~ ([Figures 2](#fig2){ref-type="fig"}B and 2D--2F). It was possible that, upon H~2~O~2~ treatment, increased levels of Tpx1 disulfides ([Figure S1](#app2){ref-type="sec"}) might indirectly promote Txl1 oxidation by increasing the levels of oxidized Trx1 and thus limiting the Trr1 available to reduce Txl1 ([@bib7]). However, the increased proportion of Tpx1 disulfides detected in (1) Δ*txl1* cells compared with wild-type cells, and (2) Δ*trx1*Δ*txl1* cells compared with Δ*trx1* cells, suggests that Txl1 may also directly reduce Tpx1 disulfides ([Figure 2](#fig2){ref-type="fig"}C). The H~2~O~2~-induced oxidation of Trx1 is dependent on the thioredoxin peroxidase activity of Tpx1 ([@bib7]). Similarly, Flag-Txl1 was not oxidized in Δ*tpx1* cells treated with 0.2 mM H~2~O~2~ ([Figure 2](#fig2){ref-type="fig"}D) or in cells expressing a catalytically inactive Tpx1 mutant protein, Tpx1^C169S^, in which the resolving cysteine is substituted with serine ([Figure 2](#fig2){ref-type="fig"}E). Moreover, Flag-Txl1 remained predominantly reduced in wild-type cells treated with 6 mM H~2~O~2~, a concentration at which the thioredoxin peroxidase activity of Tpx1 is inhibited by hyperoxidation ([Figures 2](#fig2){ref-type="fig"}F and [S1](#app2){ref-type="sec"}) ([@bib7]). Together, these data reveal that the thioredoxin peroxidase activity of Tpx1 promotes the oxidation of both Txl1 ([Figure 2](#fig2){ref-type="fig"}) and Trx1 ([@bib7]), in response to H~2~O~2~.

Txl1 Regulates the H~2~O~2~-Dependent Activation of Pap1 {#sec2.3}
--------------------------------------------------------

Having established that Txl1 is a Trr1 substrate and is oxidized in response to low levels of H~2~O~2~ by a Tpx1-dependent mechanism ([Figure 2](#fig2){ref-type="fig"}), we next examined whether Txl1 regulates Pap1. In contrast to either Δ*trx1* or Δ*trr1* cells, the oxidation and nuclear accumulation of Pap1 were similar in wild-type and Δ*txl1* cells under normal growth conditions (compare [Figures 1](#fig1){ref-type="fig"}C, [3](#fig3){ref-type="fig"}A, and 3B). However, there was some indication that the levels of nuclear Pap1 were increased in Δ*txl1* cells following H~2~O~2~ treatment ([Figure 3](#fig3){ref-type="fig"}B). Indeed, although the general pattern of H~2~O~2~-induced expression of Pap1-dependent genes was similar in wild-type and Δ*txl1* cells ([Figure 4](#fig4){ref-type="fig"}), quantitative analysis indicated that basal levels of mRNA for three Pap1-dependent genes, *gst2*^*+*^, *srx1*^*+*^, and *obr1*^*+*^, were all significantly increased ([Table S1](#app2){ref-type="sec"}). Moreover, *gst2*^*+*^ mRNA levels remained elevated for longer following H~2~O~2~ treatment in Δ*txl1* cells than wild-type cells ([Figure 4](#fig4){ref-type="fig"}A). Because nuclear Pap1 is degraded by the proteasome ([@bib17]), and Txl1 is associated with the proteasome ([@bib2]), it was possible that increases in Pap1-dependent gene expression reflected an increase in Pap1 stability in Δ*txl1* cells. However, the total levels of Pap1 protein in wild-type and Δ*txl1* cells appeared similar ([Figure 3](#fig3){ref-type="fig"}A; data not shown). Instead, we examined whether Trx1 and Txl1 might have partially redundant roles in reducing Pap1, as observed for oxidized Tpx1 ([Figure 2](#fig2){ref-type="fig"}C). Indeed, a greater proportion of Pap1 was oxidized in Δ*trx1*Δ*txl1* cells compared with unstressed Δ*trx1* cells ([Figures 3](#fig3){ref-type="fig"}A and 3B; data not shown). Moreover, consistent with the hypothesis that Txl1 and Trx1 independently repress Pap1-dependent gene expression, the levels of *gst2*^*+*^, *srx1*^*+*^, and *obr1*^*+*^ mRNA were all substantially higher in unstressed Δ*trx1*Δ*txl1* cells compared with either single mutant ([Figure 4](#fig4){ref-type="fig"}).

Notably, although the nuclear levels of Pap1 appeared similar in Δ*trx1*Δ*txl1* and Δ*trr1* cells ([Figure 3](#fig3){ref-type="fig"}B), a significantly smaller proportion of Pap1 was oxidized in Δ*trx1*Δ*txl1* cells compared with either Δ*trr1* or wild-type cells treated with H~2~O~2~ ([Figures 3](#fig3){ref-type="fig"}A and 3C). Moreover, in contrast to Δ*trx1* cells, the proportion of oxidized Pap1 did not increase further in Δ*trx1*Δ*txl1* cells following H~2~O~2~ treatment ([Figures 3](#fig3){ref-type="fig"}A and 3C; [Table S2](#app2){ref-type="sec"}). Intriguingly, a substantial pool of reduced Pap1 that was resistant to H~2~O~2~-induced oxidation was also detected in Δ*trx1*Δ*txl1*Δ*trr1* cells ([Figure 5](#fig5){ref-type="fig"}A). Thus, collectively, these data suggest that, although loss of Trx1 and/or Txl1 increases Pap1 activity under normal conditions, Trx1 and Txl1 are also required for H~2~O~2~-induced increases in Pap1 oxidation.

Trx1 and/or Txl1 Maintains Pap1 in a Soluble, H~2~O~2~-Responsive State {#sec2.4}
-----------------------------------------------------------------------

Although the oxidation of Pap1 was always (1) increased in Δ*trx1*Δ*txl1* cells compared with either single mutant, and (2) noninducible by H~2~O~2~, there was some variation in the proportion of Pap1 that was oxidized between individual experiments ([Table S2](#app2){ref-type="sec"}). Furthermore, in contrast to Δ*trx1*, Δ*txl1*, and Δ*trr1* cells, where the fold induction of *gst2*^*+*^, *srx1*^*+*^, and *obr1*^*+*^ was remarkably consistent between individual experiments (as reflected by the small error bars in [Figure 4](#fig4){ref-type="fig"}A), although consistently high, the fold increase in each mRNA in Δ*trx1*Δ*txl1* cells varied considerably between experiments ([Table S3](#app2){ref-type="sec"}). When we explored the basis for the variation in Pap1 activity between different cultures of the Δ*trx1*Δ*txl1* strain, we discovered that, although *pap1*^*+*^ mRNA levels were similar in all of the other strains and not significantly affected by H~2~O~2~, *pap1*^*+*^ mRNA levels were significantly higher in Δ*trx1*Δ*txl1* cells and varied considerably between cultures ([Figure 4](#fig4){ref-type="fig"}B; [Table S3](#app2){ref-type="sec"}). Indeed, the variation in the fold induction of Pap1-dependent gene expression observed between the individual experiments correlated directly with the variation in the level of *pap1*^*+*^ mRNA in Δ*trx1*Δ*txl1* cells ([Table S3](#app2){ref-type="sec"}). Taken together, these data strongly suggest that increased levels of *pap1*^*+*^ mRNA contribute to the increased levels of Pap1-dependent gene expression in Δ*trx1*Δ*txl1* cells ([Table S3](#app2){ref-type="sec"}). Given the constitutive activation of Pap1 in Δ*trx1*Δ*txl1* cells, it was surprising to uncover a mechanism leading to increased *pap1*^*+*^ gene expression ([Figure 4](#fig4){ref-type="fig"}; [Table S3](#app2){ref-type="sec"}). Intriguingly, the presence of reduced Pap1 in Δ*trx1*Δ*txl1* cells that is not oxidized following H~2~O~2~ treatment ([Figures 3](#fig3){ref-type="fig"}A, 3C, and [5](#fig5){ref-type="fig"}A) suggested that these cells contain a pool of reduced Pap1 that is insensitive to oxidation. Indeed, although Δ*trx1*Δ*txl1* cells contain similar total levels of Pap1 protein to other strains ([Figure 5](#fig5){ref-type="fig"}B, whole-cell lysates), when extracts were prepared under nondenaturing conditions (which do not preserve the in vivo thiol-redox state), Pap1 levels were markedly lower in Δ*trx1*Δ*txl1* cells than in other strains ([Figure 5](#fig5){ref-type="fig"}B, soluble proteins). This suggests that the majority of Pap1 in Δ*trx1*Δ*txl1* cells is insoluble and, hence, resistant to extraction under nondenaturing conditions ([Figure 5](#fig5){ref-type="fig"}B, compare soluble proteins with whole-cell lysates). These data suggest that Trx1 and/or Txl1 is required to maintain Pap1 in a reduced, soluble form that can be activated by oxidation. Notably, wild-type levels of soluble Pap1 were maintained in Δ*trr1* cells ([Figure 5](#fig5){ref-type="fig"}B), in which Txl1 is completely oxidized ([Figure 2](#fig2){ref-type="fig"}B), and levels of oxidized Trx1 are increased ([Figure S2](#app2){ref-type="sec"}). In contrast, a pool of nonoxidizable, insoluble Pap1 was present in Δ*trx1*Δ*txl1*Δ*trr1* cells ([Figure 5](#fig5){ref-type="fig"}A; data not shown). Although these data could indicate positive roles for oxidized Trx1 and Txl1 in Pap1 activation, Δ*trr1* cells also contain significant levels of reduced Trx1, which may be responsible for maintaining Pap1 in a soluble form that can be oxidized ([Figure S2](#app2){ref-type="sec"}). Together, these data suggest that Trx1 and Txl1 have redundant roles in maintaining Pap1 in a soluble, oxidizable form ([Figure 5](#fig5){ref-type="fig"}) and feedback inhibition of *pap1*^*+*^ gene expression ([Figure 4](#fig4){ref-type="fig"}B).

The Thioredoxin Peroxidase Activity of Tpx1 Is Required to Prevent Direct, Txl1-Mediated Reduction of Pap1 {#sec2.5}
----------------------------------------------------------------------------------------------------------

Cytoplasmic Trxs have recently been shown to be important for oxidative folding of certain mitochondrial proteins by preventing premature oxidation in the cytoplasm prior to mitochondrial import ([@bib11]). To test whether Trx1 or Txl1 might have a similar role in preventing inappropriate oxidation of Pap1, we looked for evidence that Trx1 and/or Txl1 directly regulates the oxidation/reduction of Pap1 in vivo. Txl1 has been demonstrated to reduce a model oxidized substrate in vitro, but in vivo substrates have not been established ([@bib2]). The oxidoreductase activities of thioredoxin family proteins such as Trx1 and Txl1 involve two cysteine residues within a CGPC motif ([@bib19; @bib25]). The reduction mechanism involves the formation of an intermediate mixed disulfide between one of these cysteines and the oxidized substrate protein. Hence, to determine if Txl1 is directly involved in the reduction of Pap1 in vivo, we first examined whether Txl1 and Pap1 form a mixed disulfide complex(es). Although we could not detect potential Pap1-Txl1 mixed disulfide complexes when comparing extracts from wild-type and Δ*txl1* cells treated with H~2~O~2~ (data not shown), we reasoned that such complexes might be difficult to detect due to their likely transient nature. The peroxidatic and resolving catalytic cysteine residues of Tpx1 are both essential for normal in vivo thioredoxin peroxidase activity ([Figure 2](#fig2){ref-type="fig"}E; [@bib7]) and H~2~O~2~-induced activation of Pap1 ([@bib3; @bib37]). However, whereas the H~2~O~2~-induced oxidation of Pap1 is completely dependent on the peroxidatic cysteine residue, in cells expressing Tpx1^C169S^, where the resolving cysteine is substituted with serine, Pap1 still forms H~2~O~2~-induced HMW disulfide complexes ([Figures 6](#fig6){ref-type="fig"}A and 6B) ([@bib37]). Despite considerable effort, we have found no evidence that these Pap1 HMW complexes contain either Tpx1 or Trx1 ([@bib3]; [Figure S3](#app2){ref-type="sec"}). To investigate whether any of these Pap1 HMW complexes represent mixed disulfide complexes with Txl1, we compared the mobilities of complexes formed in Tpx1^C169S^-expressing cells containing either wild-type Txl1 or Flag epitope-tagged Txl1 (Flag-Txl1). As expected, HMW complexes containing Pap1 were detected in cells expressing Tpx1^C169S^ from the normal chromosomal locus, and these increased following H~2~O~2~ treatment ([Figure 6](#fig6){ref-type="fig"}A). Strikingly, a complex with the predicted MW for a Txl1-Pap1 disulfide (asterisk \[^∗^\] in [Figure 6](#fig6){ref-type="fig"}A) was observed in both untreated and H~2~O~2~-treated Txl1-containing cells. Consistent with the hypothesis that this was a Txl1-Pap1 disulfide, this band (^∗^) was not present in cells expressing Flag-Txl1, and a new lower mobility band (\#) was detected instead ([Figure 6](#fig6){ref-type="fig"}A). Unfortunately, the new putative Flag-Txl1-Pap1 disulfide band was of a similar mobility to a ns band, making it difficult to resolve the two bands. The new putative Flag-Txl1-Pap1 band was also less intense, perhaps reflecting that Flag-Txl1 levels are lower than levels of endogenous Txl1, although in the absence of a specific Txl1 antibody, this could not be confirmed. We also observed that the mobility of several HMW Pap1 disulfide complexes, induced following exposure to H~2~O~2~ (indicated by arrowheads), was very slightly decreased in cells expressing Flag-Txl1 ([Figure 6](#fig6){ref-type="fig"}A). These slight decreases in mobility were consistent with the effect of a Flag epitope tag, suggesting that these complexes may also contain Txl1 ([Figure 6](#fig6){ref-type="fig"}A).

These data suggest that Txl1 is directly involved in the oxidation/reduction of Pap1. To test this hypothesis, Pap1 oxidation was next examined in wild-type and Δ*txl1* cells expressing Tpx1^C169S^. Notably, many of the HMW forms of Pap1 that were detected in cells expressing Tpx1^C169S^ were no longer detected in Δ*txl1* cells, including the band with the expected mobility of a Txl1-Pap1 disulfide present in untreated *txl1*^*+*^ cells ([Figure 6](#fig6){ref-type="fig"}B, compare lanes 3--6). Furthermore, loss of Txl1 restored wild-type H~2~O~2~-induced Pap1 oxidation to Tpx1^C169S^-expressing cells ([Figure 6](#fig6){ref-type="fig"}B, compare lanes 2 and 6). Excitingly, this suggests that Txl1 reduces Pap1, inhibiting the H~2~O~2~-induced formation of fully oxidized, active forms. Strikingly, it also suggests that the sole function of the resolving cysteine of Tpx1 in H~2~O~2~-induced activation of Pap1 is to promote Txl1 oxidation ([Figure 2](#fig2){ref-type="fig"}E) and, thus, prevent Txl1 from reducing Pap1 ([Figures 6](#fig6){ref-type="fig"}A and 6B). This raised the possibility that the failure to inhibit Txl1 underlies the increased H~2~O~2~ sensitivity of Tpx1^C169S^-expressing cells. Significantly, consistent with this hypothesis, loss of Txl1 restored wild-type levels of H~2~O~2~ resistance to Tpx1^C169S^-expressing cells ([Figure 6](#fig6){ref-type="fig"}C). Collectively, these data suggest that the essential role for the thioredoxin peroxidase activity of Tpx1 in adaptation to H~2~O~2~ is to promote the H~2~O~2~-induced oxidation of Txl1 and, thus, allow H~2~O~2~ signal transduction ([Figures 7](#fig7){ref-type="fig"} and [S4](#app2){ref-type="sec"}).

Discussion {#sec3}
==========

Here, we present a mechanism for the sensing and propagation of an H~2~O~2~ signal that is mediated by the thioredoxin peroxidase activity of the 2-Cys Prx, Tpx1. Strikingly, we show that this signaling activity is dependent on the ability of Tpx1 to promote the H~2~O~2~-dependent oxidation of a conserved thioredoxin family protein, Txl1 (human TRP32/Txnl1). We have identified the Pap1 transcription factor as an in vivo substrate for Txl1. We show that reduced Txl1 directly inhibits Pap1, preventing the accumulation of its active, oxidized form. We demonstrate that the critical role of the thioredoxin peroxidase activity of Tpx1 in the H~2~O~2~-dependent activation of Pap1 is to promote Txl1 oxidation and thus prevent Txl1 from reducing Pap1.

Thioredoxin family proteins, including Trx1 and Txl1, are highly conserved, acting as crucial cofactors for many enzymes and as redox-sensitive inhibitors of various signaling proteins ([@bib22]). Hence, as discussed below, our data have broader implications for the mechanisms mediating H~2~O~2~ signal transduction. For instance, our model suggests that the relative levels of the thioredoxin reductase Trr1, which reduces Trx1 and Txl1, and the 2-Cys Prx Tpx1, which drives Trx1 and Txl1 oxidation, are key in determining the H~2~O~2~ responsivity of Pap1 ([Figure 7](#fig7){ref-type="fig"}). Indeed, this model explains the observation that overexpression of Tpx1 increases the activation of Pap1 by H~2~O~2~ ([@bib3]). Moreover, consistent with the idea that for effective adaptation to H~2~O~2~ it is important that levels of thioredoxin reductase are limiting, overexpression of Trr1 actually reduces the resistance of wild-type cells to H~2~O~2~ ([Figure S5](#app2){ref-type="sec"}).

Role of Trx1 and Txl1 in Regulation of Pap1 {#sec3.1}
-------------------------------------------

The limited effect of loss of Txl1 on the activation of Pap1 compared with loss of both Trx1 and Txl1 ([Figures 3](#fig3){ref-type="fig"} and [4](#fig4){ref-type="fig"}) points to redundancy between Trx1 and Txl1 in the reduction of oxidized Pap1. Nonetheless, we have been unable to find any evidence that Trx1 directly reduces Pap1 in vivo (such as Trx1-Pap1 disulfides), even in cells lacking Txl1 ([Figures 6](#fig6){ref-type="fig"}B and [S3](#app2){ref-type="sec"}). Moreover, because Trx1 is excluded from the nucleus, it is unlikely to be involved in reducing nuclear, oxidized Pap1 ([Figure 2](#fig2){ref-type="fig"}A) ([@bib7]). Previous studies have shown that Txl1 and the mammalian homolog, Txnl1/TRP32, associate with the proteasome ([@bib1; @bib39]). Although this suggests that Txl1 might be involved in the degradation of oxidized proteins ([@bib2]), we did not detect any increase in Pap1 levels in unstressed or H~2~O~2~-treated cells lacking Txl1 ([Figure 5](#fig5){ref-type="fig"}). This suggests that mechanisms to target nuclear, oxidized Pap1 for proteasomal degradation are sufficient to compensate for loss of Txl1 ([@bib17]).

The partial oxidation ([Figure 5](#fig5){ref-type="fig"}A) and constitutive activity ([Figure 4](#fig4){ref-type="fig"}A) of Pap1 in Δ*trx1*Δ*txl1* cells indicate that Trx1 and Txl1 are not required for the activation of Pap1. However, intriguingly, we have discovered that there is a significant pool of Pap1 that is insoluble ([Figure 5](#fig5){ref-type="fig"}B) and resistant to oxidation in Δ*trx1*Δ*txl1* cells ([Figure 5](#fig5){ref-type="fig"}A) in which there is a complete absence of thioredoxin activity (e.g., [Figure 2](#fig2){ref-type="fig"}C). This suggests that Trx1 and Txl1 have semiredundant functions in maintaining Pap1 in a soluble form that is sensitive to oxidation. Hence, the most likely explanation for the increased *pap1*^*+*^ gene expression in Δ*trx1*Δ*txl1* cells ([Figure 4](#fig4){ref-type="fig"}B; [Table S3](#app2){ref-type="sec"}) is that a negative feedback mechanism, monitoring levels of thioredoxin and/or soluble Pap1, is disrupted in these cells ([Figure S4](#app2){ref-type="sec"}).

In the evolutionarily distant yeast *S. cerevisiae*, the Pap1-related Yap1 transcription factor is also oxidized and activated in response to H~2~O~2~. Depending on the strain background, either the thioredoxin peroxidase Gpx3 or the Tpx1 ortholog, Tsa1, is essential for the H~2~O~2~-induced oxidation and activation of Yap1 ([@bib9; @bib28; @bib33]). Intermolecular disulfide bonds between either Gpx3 or Tsa1 and Yap1 have been detected and proposed to initiate the H~2~O~2~-induced oxidation of Yap1 ([@bib9; @bib31]). It is possible that, in addition to promoting the oxidation of Trx1 and Txl1, Tpx1 is also directly involved in the initiation of Pap1 oxidation. However, no intermolecular disulfide bond(s) has been detected between Pap1 and Tpx1 ([@bib3; @bib37]). Moreover, loss of Tpx1 does not prevent the constitutive oxidation and activation of Pap1 in cells lacking Trr1 ([Figure 1](#fig1){ref-type="fig"}). Thus, although Tpx1 is normally required for H~2~O~2~-induced activation, Pap1 can also be oxidized by a Prx-independent mechanism. We cannot rule out the possibility that another peroxidase directly transduces H~2~O~2~ signals to Pap1, similar to Gpx3-dependent regulation of Yap1 in *S. cerevisiae*. However, Pap1 is oxidized to a similar extent in Δ*trr1* cells and in Δ*gpx1*Δ*tpx1*Δ*trr1* cells, lacking both Tpx1 and Gpx1, the Gpx3 ortholog (data not shown). Thus, our data are consistent with a model whereby Pap1 can be directly oxidized, perhaps by a mechanism involving the initial formation of HMW Pap1-Pap1 disulfide complexes.

The Role of Prxs as Regulators of Thioredoxin Family Proteins {#sec3.2}
-------------------------------------------------------------

Prxs are multifunctional enzymes that make significant contributions to the oxidative stress resistance, genome stability, and longevity of unicellular eukaryotes, plants, and animals (for a review, see [@bib27]). Although Prxs also have a chaperone activity that may be important for protein homeostasis, it is assumed that detoxification of peroxides by the thioredoxin peroxidase activity of these enzymes makes an important contribution to many of these biological roles (for reviews, see [@bib27; @bib29]). Our previous discovery that the thioredoxin peroxidase activity of Tpx1 actually reduces the survival of cells exposed to acutely toxic levels of H~2~O~2~ by inhibiting thioredoxin-mediated repair processes ([@bib7]) led us to the hypothesis tested here that a major function of Prxs in response to low, signaling levels of H~2~O~2~ is to oxidize thioredoxin. Notably, there is evidence that Prx-mediated inhibition of a thioredoxin family protein is also important for signaling in plants ([@bib6]). Strikingly, we find that an H~2~O~2~-signaling role, as a regulator of Txl1, is the major function for the thioredoxin peroxidase activity of Tpx1 in the oxidative stress resistance of *S. pombe* ([Figure 6](#fig6){ref-type="fig"}). These data raise the possibility that the function of Prxs, as peroxide-dependent regulators of thioredoxin family proteins, makes an important contribution to their roles in oxidative stress responses, cancer, and aging ([@bib27; @bib29]).

Broader Implications for H~2~O~2~ Signaling {#sec3.3}
-------------------------------------------

Thioredoxins are broad specificity oxidoreductases ([@bib22]). Consequently, it is likely that Txl1 reduces other protein substrates, in addition to Tpx1 and Pap1. Indeed, a recent study suggested that the human Txl1 homolog, TRP32, reduces a protein tyrosine phosphatase, PRL, that regulates various signaling pathways ([@bib14]). Hence, an important implication of our work is that the coupling of the redox state of Txl1 and Trx1 to the thioredoxin peroxidase activity of Tpx1 provides a means to regulate other Trx1 and Txl1 substrates in response to H~2~O~2~. This model predicts that the relative activities of thioredoxin reductase, which reduces thioredoxin family proteins, and Prxs, which promote their oxidation, play a vital role in determining cell responses to H~2~O~2~ ([Figure 7](#fig7){ref-type="fig"}).

H~2~O~2~ signals promote cell growth and diverse responses, such as cell migration and differentiation. ROS signals have also been shown to slow organismal aging ([@bib42; @bib43]). However, the targets responsible for many of these ROS-mediated effects are unclear. Our study raises the exciting prospect that enzyme activities, not previously connected with H~2~O~2~ signal transduction, might be subject to Prx-dependent regulation in cells, such as *S. pombe*, where thioredoxin reductase activity is limiting. For example, Prx-mediated inhibition of thioredoxin may provide a mechanism to inactivate thioredoxin-dependent enzymes in response to H~2~O~2~.

It remains to be determined whether the mechanisms presented here contribute to the regulation of H~2~O~2~ signal transduction in multicellular eukaryotes. It is possible that inhibition of thioredoxin family proteins underlies some of the positive roles of mammalian Prx in H~2~O~2~ signaling. For instance, Prx-mediated inhibition of thioredoxin may promote the H~2~O~2~-induced activation of the many signaling proteins that are inhibited by thioredoxin (for a review, see [@bib23]). However, mammalian Prxs have also been shown to inhibit H~2~O~2~ signaling by removing H~2~O~2~ ([@bib40; @bib29]). It is tempting to speculate that, in these cases, thioredoxin reductase levels are not limiting, and hence, Prx activity has a greater effect on the levels of H~2~O~2~ available for signaling than on thioredoxin activity. Indeed, a further implication of this study is that regulating the relative abundance/activities of thioredoxin reductase and thioredoxin peroxidase enzymes within a particular cell/cell compartment could be an effective means to tailor the H~2~O~2~ sensitivity of specific cells/pathways. Accordingly, the mechanisms presented here provide a framework that will be important for fully understanding how cells/organisms utilize H~2~O~2~ as a signaling molecule.

Experimental Procedures {#sec4}
=======================

Yeast Strains and Growth Conditions {#sec4.1}
-----------------------------------

*S. pombe* strains are listed in [Table S4](#app2){ref-type="sec"}. Plasmids and strains are described in the [Supplemental Experimental Procedures](#app2){ref-type="sec"}. Strains were grown at 30°C with rich medium (YE5S) or minimal media (EMM) with essential supplements ([@bib26]). Kanamycin resistance was detected using YE5S media containing 200 μg/ml G418 disulfate (Melford).

Analysis of Soluble Pap1 Levels and the Oxidation State of Pap1, Tpx1, and Txl1 {#sec4.2}
-------------------------------------------------------------------------------

A total of 3.75--7.5 × 10^6^ exponentially growing cells expressing Pap1, Tpx1, or Flag epitope-tagged Txl1 (Flag-Txl1) were harvested before or after exposure to the indicated concentration of H~2~O~2~. For analysis of soluble Pap1 levels, protein was extracted as described previously ([@bib32]) using a nondenaturing procedure in lysis buffer (50 mM Tris-HCl \[pH 7.5\], 150 mM NaCl, 0.5 g/100 ml Nonidet P-40 with 2 μg/ml pepstatin A, 2 μg/ml leupeptin, 100 mg/ml phenylmethylsulfonyl fluoride, and 1 ml/100 ml aprotinin), and extracts were clarified. For determination of oxidation state, cells were harvested following addition of trichloroacetic acid (TCA) to a final concentration of 10%. Lysates were prepared essentially as described previously by [@bib8]. Proteins were resuspended in either 200 mM Tris-HCl (pH 8.0), 1% w/v SDS, and 1 mM EDTA containing 4-acetamido-4′-((iodoacetyl)amino)stilbene-2,2′-disulfonic acid (AMS) (Invitrogen) (Flag-Txl1 or Tpx1), or 100 mM Tris-HCl (pH 8.0), 1% w/v SDS, and 1 mM EDTA containing 75 mM iodoacetamide (IAA) (Pap1) as indicated. For Pap1, lysates were also treated with alkaline phosphatase (Roche Diagnostics).

Equivalent amounts of thiol-modified (AMS or IAA) and unmodified proteins were separated by nonreducing 8% (Pap1) or 10% (Flag-Txl1 or Tpx1) SDS-PAGE and transferred to a Protran nitrocellulose membrane (Whatman) prior to incubation with monoclonal M2 Flag antibody (Sigma-Aldrich) for Flag-Txl1, rabbit polyclonal Pap1 antibody for Pap1 (provided by Nic Jones and Caroline Wilkinson), or rabbit polyclonal Tpx1 antibody for Tpx1 ([@bib7]). Horseradish peroxidase-conjugated anti-rabbit (Pap1 or Tpx1) or anti-mouse (Flag-Txl1) IgG secondary antibodies were used together with the ECL detection system (Amersham Biosciences) to visualize proteins on film (Fuji) or using a Typhoon FLA9500. Quantitative densitometric analyses of western blots were conducted using ImageJ 1.44 or ImageQuant.

Analysis of mRNA {#sec4.3}
----------------

RNA was extracted from 2.5--3 × 10^8^ exponentially growing cells cultured in YE5S harvested before and after treatment with H~2~O~2~ as previously described ([@bib32]). RNA was analyzed using glyoxal gels and northern blotting with ^32^P-dCTP-labeled gene-specific probes in QuikHyb (Stratagene). Phosphorimager analysis was conducted using a GE Typhoon FLA9500 and ImageQuant software.

Immunolocalization {#sec4.4}
------------------

To investigate cellular localization of Pap1, Flag-Trx1, and Flag-Txl1, exponentially growing cells were fixed and immunostained as described previously ([@bib32]) using either polyclonal Pap1 or monoclonal Flag antibodies and either Alexa-conjugated anti-rabbit or anti-mouse IgG secondary antibodies, respectively ([@bib32]). Wild-type and Δ*pap1* cells were stained with either Flag or Pap1 antibodies, respectively, as controls. Immunostained cells were mounted in VECTASHIELD containing DAPI (Vector Laboratories) to detect nuclei. Stained cells were analyzed using a Zeiss Axio Scope fluorescence microscope, and images were obtained using identical exposures within each experiment with the AxioVision imaging system.

Statistical Analysis of Data {#sec4.5}
----------------------------

All experiments were repeated at least three times on independently generated samples with similar results. Representative experiments or the quantitative densitometric analysis of several experiments are shown.

Supplemental Information {#app2}
========================

Document S1. Supplemental Experimental Procedures, Figures S1--S5, and Tables S1--S4Document S2. Article plus Supplemental Information
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![Loss of the Thioredoxin Reductase, Trr1, but Not Trx1, Bypasses the Requirement for Tpx1 in the Oxidation and Nuclear Localization of Pap1\
(A) The catalytic cycle of the Prx, Tpx1, involves reduction of Tpx1 disulfides by the thioredoxin, Trx1. Oxidized Trx1 is reduced by thioredoxin reductase using NADPH. In cells treated with H~2~O~2~, Trr1 levels are limiting such that Trx1 becomes completely oxidized unless Tpx1 becomes hyperoxidized ([@bib7]). The question marks ("?") indicate that the role of Trx1 and Tpx1 in oxidation of Pap1 is unclear; it is possible that (i) Tpx1 disulfides competitively inhibit the reduction of oxidized, active Pap1 by Trx1, and/or (ii) Tpx1 has another role in Pap1 oxidation.\
(B--D) Tpx1 is required for the oxidation of Pap1 in Δ*trx1* but not Δ*trr1* mutant cells as revealed by western blot analysis, using Pap1 antibodies, of IAA-treated proteins isolated from wild-type (WT; AD82), Δ*tpx1* (VXOO), Δ*trx1* (JB30), Δ*trr1* (AD81), Δ*tpx1*Δ*trx1* (AD100), and Δ*tpx1*Δ*trr1* (AD138) cells treated with 0.2 mM H~2~O~2~ for the indicated times. Oxidized (Pap1^ox^) and reduced (Pap1^red^) Pap1 were separated on the basis of the slower mobility of Pap1 following modification of reduced cysteines with IAA. Results in (B) and (C) are representative of at least three independent experiments. (D) The proportion of oxidized Pap1 was determined by densitometric analysis (ImageJ) quantification of oxidized and total Pap1 in at least three independent experiments. The mean percentage of oxidized Pap1 is shown, and the error bars indicate the SEM.\
(E) Immunostaining with Pap1 antibodies revealed the localization of Pap1 in wild-type (AD82), Δ*tpx1* (VXOO), Δ*trx1* (JB30), Δ*trr1* (AD81), Δ*tpx1*Δ*trx1* (AD100), and Δ*tpx1*Δ*trr1* (AD138) cells before and following treatment with 0.2 mM H~2~O~2~ for the indicated times. Each image was captured under identical conditions and exposure time.\
See also [Figure S1](#app2){ref-type="sec"}.](gr1){#fig1}

![The Thioredoxin-like Protein Txl1 Is Present in the Nucleus and Cytoplasm and Is Regulated by H~2~O~2~ in a Tpx1- and Trr1-Dependent Manner\
(A) Immunolocalization with Flag antibodies of Flag epitope-tagged Txl1 (Flag-Txl1; JB95) and Trx1 (Flag-Trx1; JB35) expressed from their normal chromosomal loci, respectively, revealed that Flag-Txl1 is distributed throughout the cell, whereas Flag-Trx1 is excluded from the nucleus both before and following treatment with 0.2 mM H~2~O~2~. Nuclei were detected by DAPI staining.\
(B) Txl1 is oxidized by H~2~O~2~ and reduced by Trr1. The redox state of Flag-Txl1 expressed from the normal chromosomal locus was analyzed by western blot using extracts prepared by acid lysis and AMS treatment from *trr1*^*+*^ (JB95) and Δ*trr1* (JB116) cells treated with 0.2 mM H~2~O~2~ for the indicated times. Oxidized (Txl1^ox^) and reduced (Txl1^red^) Flag-Txl1 were separated on the basis of the slower mobility of Txl1 following AMS modification of reduced cysteines.\
(C) Western blot analysis of the oxidation state of Tpx1 in wild-type (AD82), Δ*trx1* (JB30), Δ*txl1* (EV75), and Δ*trx1*Δ*txl1* (AD140) cells before and following treatment with 0.2 mM H~2~O~2~ for the indicated times revealed that Trx1 and Txl1 are both required for reduction of Tpx1-Tpx1 disulfides. AMS modification of reduced cysteines was used to separate Tpx1-Tpx1 single disulfides (^∗^) from Tpx1-Tpx1 disulfides containing two disulfide bonds (\#) in which all cysteines are oxidized.\
(D--F) The redox state of Flag-Txl1 was determined by western blot analysis of AMS-modified proteins prepared from (D) *tpx1*^*+*^ (JB95) and Δ*tpx1* (JB113), (E) *tpx1*^*+*^ (JB95) and *tpx1*^*C169S*^ (JB107), and (F) *tpx1*^*+*^ (JB95) cells expressing Flag-Txl1 from the normal chromosomal locus before and following treatment with 0.2 or 6 mM H~2~O~2~ as indicated.\
In (B) and (D)--(F), ns bands that are detected with Flag antibodies in cells expressing wild-type Txl1 (CHP429) are indicated, including a band with a similar mobility to oxidized Flag-Txl1 that is detected in cells before H~2~O~2~ treatment. (B and D--F) Oxidized (Txl1^ox^) and reduced (Txl1^red^) Flag-Txl1 were detected using Flag antibodies, and reduced Tpx1 (Tpxl^red^) and Tpx1 disulfides were detected using Tpx1 antibodies.](gr2){#fig2}

![Txl1 and Trx1 Have Overlapping Functions as Inhibitors of the H~2~O~2~-Induced Activation of Pap1\
Txl1 and Trx1 have overlapping functions as inhibitors of Pap1 activation as revealed by (A and C) western blot analysis using Pap1 antibodies of IAA-treated protein extracts prepared from wild-type (AD82), Δ*txl1* (EV75), Δ*trx1* (JB30), Δ*trr1* (AD81), and Δ*trx1*Δ*txl1* (AD140) cells treated with 0.2 mM H~2~O~2~ for the indicated times. Oxidized (Pap1^ox^) and reduced (Pap1^red^) Pap1 were separated on the basis of their different electrophoretic mobility following IAA modification of reduced cysteines.\
(B) The localization of Pap1 in midlog phase-growing wild-type (AD82), Δ*txl1* (EV75), Δ*trx1* (JB30), Δ*trr1* (AD81), and Δ*trx1*Δ*txl1* (AD140) cells treated with 0.2 mM H~2~O~2~ for the indicated times was examined by indirect immunofluorescence using Pap1 antibodies. Each image was captured under identical conditions and exposure time.\
See also [Table S2](#app2){ref-type="sec"}.](gr3){#fig3}

![Trx1 and Txl1 Inhibit *pap1*^*+*^ and Pap1-Dependent Gene Expression\
Northern blot analyses of RNA extracted from midlog phase-growing wild-type (AD82), Δ*txl1* (EV75), Δ*trx1* (JB30), Δ*trr1* (AD81), and Δ*trx1*Δ*txl1* (AD140) cells treated with 0.2 mM H~2~O~2~ for the indicated times. Gene-specific probes were used to detect RNA from the indicated genes. A gene-specific probe for *leu1*^*+*^ was used as a loading control (see also [Table S1](#app2){ref-type="sec"}).\
(A) A representative blot of the indicated Pap1-dependent genes and the graphs show the quantitative analyses of three independent experiments plotted as the mean fold induction of each mRNA relative to wild-type. Error bars represent the SEM.\
(B) A representative blot is shown from three independent experiments illustrating the increased *pap1*^*+*^ mRNA levels detected in Δ*trx1*Δ*txl1* cells. For quantified experimental data from each experiment.\
See [Table S3](#app2){ref-type="sec"}.](gr4){#fig4}

![Trx1 and Txl1 Are Important for Maintaining Pap1 in a Soluble Form that Can Be Oxidized in Response to H~2~O~2~\
(A) Western blot analysis of the oxidation state of Pap1 in wild-type (AD82), Δ*trx1*(JB30), Δ*trr1*(AD81), Δ*trx1*Δ*txl1*(AD140), and Δ*trx1*Δ*txl1*Δ*trr1* (JB120) cells before and following treatment with 0.2 mM H~2~O~2~ for 10 min reveals that in the absence of Txl1 and Trx1, there is a pool of reduced Pap1 that is not oxidized following exposure to H~2~O~2~.\
(B) Western blot analysis of Pap1 in extracts prepared under native (soluble) and denaturing (whole-cell lysate) conditions from the indicated strains and Δ*pap1* (TP108-3C), Δ*trx1* (JB30), Δ*trr1*(AD81), Δ*trx1*Δ*txl1*(AD140), and Δ*txl1*(EV75) reveals that, although total Pap1 levels are similar in each strain, Pap1 is undetectable in extracts from Δ*trx1*Δ*txl1* cells prepared under nondenaturing conditions. It should be noted that although, as indicated, oxidized and reduced Pap1 forms can be detected by both extraction methods, the absence of any precautions to prevent in vitro thiol exchange means that the relative levels of reduced and oxidized Pap1 in the soluble protein extracts are not a reliable indicator of the in vivo oxidation state of Pap1.\
See also [Figure S2](#app2){ref-type="sec"}.](gr5){#fig5}

![Txl1 Forms Disulfide Complexes with Pap1 and Inhibits Normal H~2~O~2~-Induced Oxidation of Pap1 in Cells Expressing the Thioredoxin Peroxidase-Defective Tpx1^C169S^\
Western blot analysis, using Pap1 antibodies, of the redox status of Pap1 in (A) cells expressing Tpx1^C169S^ and coexpressing either *txl1*^*+*^ (−; JR42) or Flag-Txl1 (+; JB107) from their normal chromosomal loci before and following treatment with 0.2 mM H~2~O~2~ for the indicated times. Bands with a mobility that is consistent with Txl1-Pap1 (^∗^) and Flag-Txl1-Pap1 (\#) disulfides are indicated on the blot and in a selected area (white rectangle) magnified on the right-hand side of the panel. HMW Pap1 disulfides in cells expressing Flag-Txl1 whose slight reduction in mobility is consistent with the presence of the Flag epitope are also indicated (arrowheads).\
(B) Western blot analysis of wild-type (AD82) cells, and either *txl1*^+^ (JR42) or Δ*txl1* (JB92) cells coexpressing Tpx1^C169S^ from the normal chromosomal locus, before and following treatment with 0.2 mM H~2~O~2~ for 1 min revealed that loss of Txl1 restores normal wild-type oxidation of Pap1, and inhibits formation of HMW Pap1 disulfide complexes, in cells expressing Tpx1^C169S^.\
(C) Loss of Txl1 function restores the H~2~O~2~ resistance of cells expressing Tpx1^C169S^. The 10-fold serial dilutions of exponentially growing wild-type (JR68), Δ*txl1* (JB99), *tpx1*^*C169S*^*txl1*^+^ (JR42), and *tpx1*^*C169S*^Δ*txl1* (JB92) cells were spotted onto media containing the indicated concentration of H~2~O~2~. Plates were incubated at 30°C for 2--3 days.\
See also [Figure S3](#app2){ref-type="sec"}.](gr6){#fig6}

![Model Illustrating How the Thioredoxin Peroxidase Activity of Prxs Can Promote H~2~O~2~ Signaling by Regulating Thioredoxin Family Proteins\
Thioredoxin family proteins are cofactors for multiple enzymes as well as important inhibitors of various H~2~O~2~-signaling pathways. By promoting the oxidation of thioredoxin, the peroxidase activity of Prxs provides a means for the H~2~O~2~-dependent regulation of all these pathways/enzymes, particularly when thioredoxin reductase (Trr) activity is limiting. For example, in *S. pombe*, the thioredoxin peroxidase activity of Tpx1 propagates H~2~O~2~ signal transduction and increases oxidative stress resistance by driving the oxidation of the thioredoxin family protein Txl1 that directly inhibits (reduces) Pap1. Thioredoxin reductase (Trr) activity counterbalances this Prx-mediated H~2~O~2~ signaling.\
See also [Figures S4](#app2){ref-type="sec"} and [S5](#app2){ref-type="sec"}.](gr7){#fig7}
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